StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
CureVac N.V.
Frankfurt Stock Exchange:5CV.F
Sector
Location
Market Cap
USD 1.21 B
Share Price
USD 5.42
Avg Daily Volume
28,767
Change (1 day)
-0.17%
Change (1 year)
47.09%
Change (YTD)
76.47%
CureVac N.V. EBITDA for the year ending December 31, 2024: USD 217.13 M
CureVac N.V. EBITDA is USD 217.13 M for the year ending December 31, 2024, a -184.04% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
-
CureVac N.V. EBITDA for the year ending December 31, 2023 was USD -258.38 M, a 15.33% change year over year.
-
CureVac N.V. EBITDA for the year ending December 31, 2022 was USD -224.03 M, a -49.08% change year over year.
-
CureVac N.V. EBITDA for the year ending December 31, 2021 was USD -439.96 M, a 192.58% change year over year.
-
CureVac N.V. EBITDA for the year ending December 31, 2020 was USD -150.37 M, a 46.44% change year over year.
Competitors
Sanofi
USD 96.63
SAN.PA
-0.24
-0.24%
Moderna, Inc.
USD 31.26
MRNA
-0.94
-2.92%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 8.36
603392.SS
+0.02
0.20%
Swedish Orphan Biovitrum AB (publ)
USD 28.00
SOBI.ST
-0.22
-0.79%
Chongqing Zhifei Biological Products Co., Ltd.
USD 2.84
300122.SZ
-0.01
-0.52%
Ionis Pharmaceuticals, Inc.
USD 41.76
IONS
-0.41
-0.97%
Rhythm Pharmaceuticals, Inc.
USD 89.20
RYTM
-1.48
-1.63%
Shanghai Junshi Biosciences Co., Ltd.
USD 3.21
1877.HK
+0.01
0.41%
Vaxcyte, Inc.
USD 36.21
PCVX
-1.16
-3.10%
Hualan Biological Engineering Inc.
USD 2.26
002007.SZ
+0.00
0.20%
Ligand Pharmaceuticals Incorporated
USD 139.10
LGND
+1.53
1.11%
Apellis Pharmaceuticals, Inc.
USD 19.47
APLS
-0.57
-2.84%
NewAmsterdam Pharma Company N.V.
USD 22.20
NAMS
+0.22
1.00%
Apogee Therapeutics, Inc.
USD 39.31
APGE
+0.31
0.80%
Bavarian Nordic A/S
USD 28.67
BAVA.CO
+0.39
1.37%
Immunocore Holdings plc
USD 36.31
IMCR
+0.10
0.28%
ARS Pharmaceuticals, Inc.
USD 17.92
SPRY
-0.43
-2.34%
Adaptive Biotechnologies Corporation
USD 10.39
ADPT
-0.11
-1.05%
AbbVie Inc.
USD 189.26
ABBV
-2.14
-1.12%
Novo Nordisk A/S
USD 64.39
NOVO-B.CO
-1.34
-2.03%
Key Data
| Date | EBITDA | Net Income | EPS (Diluted) | Shares (Diluted, Weighted) |
|---|
Competitors
Sanofi
USD 96.63
SAN.PA
-0.24
-0.24%
Moderna, Inc.
USD 31.26
MRNA
-0.94
-2.92%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 8.36
603392.SS
+0.02
0.20%
Swedish Orphan Biovitrum AB (publ)
USD 28.00
SOBI.ST
-0.22
-0.79%
Chongqing Zhifei Biological Products Co., Ltd.
USD 2.84
300122.SZ
-0.01
-0.52%
Ionis Pharmaceuticals, Inc.
USD 41.76
IONS
-0.41
-0.97%
Rhythm Pharmaceuticals, Inc.
USD 89.20
RYTM
-1.48
-1.63%
Shanghai Junshi Biosciences Co., Ltd.
USD 3.21
1877.HK
+0.01
0.41%
Vaxcyte, Inc.
USD 36.21
PCVX
-1.16
-3.10%
Hualan Biological Engineering Inc.
USD 2.26
002007.SZ
+0.00
0.20%
Ligand Pharmaceuticals Incorporated
USD 139.10
LGND
+1.53
1.11%
Apellis Pharmaceuticals, Inc.
USD 19.47
APLS
-0.57
-2.84%
NewAmsterdam Pharma Company N.V.
USD 22.20
NAMS
+0.22
1.00%
Apogee Therapeutics, Inc.
USD 39.31
APGE
+0.31
0.80%
Bavarian Nordic A/S
USD 28.67
BAVA.CO
+0.39
1.37%
Immunocore Holdings plc
USD 36.31
IMCR
+0.10
0.28%
ARS Pharmaceuticals, Inc.
USD 17.92
SPRY
-0.43
-2.34%
Adaptive Biotechnologies Corporation
USD 10.39
ADPT
-0.11
-1.05%
AbbVie Inc.
USD 189.26
ABBV
-2.14
-1.12%
Novo Nordisk A/S
USD 64.39
NOVO-B.CO
-1.34
-2.03%